Reckitt is indeed after Merck's consumer unit, and it's ready for a close race

The rumors are true: Reckitt Benckiser has confirmed that it's in the running for Merck's ($MRK) consumer unit. As Reuters reported this weekend, Reckitt and Germany's Bayer have emerged as front-runners for the unit, which could go for $13.5 billion--or higher, if a bidding war ensues. "RB confirms that it is in discussions with Merck regarding an offer for its consumer health business," the company told the news service. "We understand that we are part of a competitive process." News | More

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.